US FDA exempts more than 100 devices from 510(k) requirements
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has exempted over 100 Class I and II medical devices from pre-market notification, or 510(k), requirements as it believes these products are sufficiently well understood and do not present risks that require pre-market notification review to assure their safety and effectiveness1,2.